Fructose downregulates miR-330 to induce renal inflammatory response and insulin signaling impairment: Attenuation by morin

Molecular Nutrition and Food Research

Volumn 61, Issue 8, 2017, Pages

  Gu, Ting Ting ^a   Song, Lin ^a   Chen, Tian Yu ^a   Wang, Xing ^a   Zhao, Xiao Juan ^a   Ding, Xiao Qin ^a   Yang, Yan Zi ^a   Pan, Ying ^a   Zhang, Dong Mei ^a   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Fructose; Kidney injury; miRNA 330; Morin; SphK1

Indexed keywords

CRYOPYRIN; FLAVONOID; FRUCTOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INSULIN; MORIN; NLRP3 PROTEIN, HUMAN; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE;

ANIMAL; CELL LINE; CHEMICALLY INDUCED; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERURICEMIA; KIDNEY PROXIMAL TUBULE; MALE; METABOLISM; NEPHRITIS; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CELL LINE; DOWN-REGULATION; FLAVONOIDS; FRUCTOSE; GENE EXPRESSION REGULATION; HUMANS; HYPERURICEMIA; INFLAMMASOMES; INSULIN; KIDNEY TUBULES, PROXIMAL; MALE; NEPHRITIS; NF-KAPPA B; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 85017265883     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600760     Document Type: Article

References (61)

1. Nakagawa, T., Tuttle, K. R., Short, R. A., Johnson, R. J., Hypothesis: fructose-induced hyperglycemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat. Clin. Pract. Nephrol. 2005, 1, 80–86.
2. Nakayama, T., Kosugi, T., Gersch, M., Connor, T. et al., Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am. J. Physiol. Renal. Physiol. 2010, 298, F712–F720.
3. Pokrywczynska, M., Flisinski, M., Jundzill, A., Krzyzanowska, S. et al., Impact of fructose diet and renal failure on the function of pancreatic islets. Pancreas 2014, 43, 801–808.
4. Akalin, N., Koroglu, M., Harmankaya, O., Akay, H. et al., Comparison of insulin resistance in the various stages of chronic kidney disease and inflammation. Ren. Fail 2015, 37, 237–240.
5. Hosoya, K., Minakuchi, H., Wakino, S., Fujimura, K. et al., Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans. Kidney Int. 2015, 87, 749–760.
6. Olefsky, J. M., Glass, C. K., Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72, 219–246.
7. Mariathasan, S., Newton, K., Monack, D. M., Vucic, D. et al., Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430, 213–218.
8. Bakker, P. J., Butter, L. M., Kors, L., Teske, G. J. et al., Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation. Kidney Int. 2014, 85, 1112–1122.
9. Fan, C. Y., Wang, M. X., Ge, C. X., Wang, X. et al., Betaine supplementation protects against high-fructose-induced renal injury in rats. J. Nutr. Biochem. 2014, 25, 353–362.
10. Ma, C. H., Kang, L. L., Ren, H. M., Zhang, D. M. et al., Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-kappaB/NLRP3 inflammasome activation in high fructose-fed rats. J. Ethnopharmacol. 2015, 172, 108–117.
11. Spiegel, S., Milstien, S., The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 2011, 11, 403–415.
12. Nagahashi, M., Hait, N. C., Maceyka, M., Avni, D. et al., Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. Adv. Biol. Regul. 2014, 54, 112–120.
13. Park, S. W., Kim, M., Kim, M., D'Agati, V. D. et al., Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation. Kidney Int. 2011, 80, 1315–1327.
14. Wang, X., Zhang, D. M., Gu, T. T., Ding, X. Q. et al., Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. Biochem. Pharmacol. 2013, 86, 1791–1804.
15. Rottiers, V., Naar, A. M., MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 2012, 13, 239–250.
16. Yang, W. M., Jeong, H. J., Park, S. W., Lee, W., Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes. Mol. Nutr. Food Res. 2015, 59, 2303–2314.
17. Rudnicki, M., Beckers, A., Neuwirt, H., Vandesompele, J., RNA expression signatures and posttranscriptional regulation in diabetic nephropathy. Nephrol. Dial. Transplant. 2015, 30(Suppl 4), iv35–iv42.
18. Wang, W., Ding, X. Q., Gu, T. T., Song, L. et al., Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377. Free Radic. Biol. Med. 2015, 83, 214–226.
19. Hou, Y. C., Chao, P. D., Ho, H. J., Wen, C. C. et al., Profound difference in pharmacokinetics between morin and its isomer quercetin in rats. J. Pharm. Pharmacol. 2003, 55, 199–203.
20. Wang, Y., Wang, Y., Wang, G. C. et al., Chemical constituents from Codariocalyx motorius. Chin. J. Nat. Med. 2007, 5, 357–359.
21. Paoli, P., Cirri, P., Caselli, A., Ranaldi, F. et al., The insulin-mimetic effect of Morin: a promising molecule in diabetes treatment. Biochim. Biophys. Acta 2013, 1830, 3102–3111.
22. Kang, D. G., Moon, M. K., Sohn, E. J., Lee, D. H. et al., Effects of morin on blood pressure and metabolic changes in fructose-induced hypertensive rats. Biol. Pharm. Bull. 2004, 27, 1779–1783.
23. Naowaboot, J., Wannasiri, S., Pannangpetch, P., Morin attenuates hepatic insulin resistance in high-fat-diet-induced obese mice. J. Physiol. Biochem. 2016, 72, 269–280.
24. Sultana, F., Rasool, M., A novel therapeutic approach targeting rheumatoid arthritis by combined administration of morin, a dietary flavanol and non-steroidal anti-inflammatory drug indomethacin with reference to pro-inflammatory cytokines, inflammatory enzymes, RANKL and transcription factors. Chem. Biol. Interact. 2015, 230, 58–70.
25. Tianzhu, Z., Shihai, Y., Juan, D., The effects of morin on lipopolysaccharide-induced acute lung injury by suppressing the lung NLRP3 inflammasome. Inflammation 2014, 37, 1976–1983.
26. Wei, Z., He, X., Kou, J., Wang, J. et al., Renoprotective mechanisms of morin in cisplatin-induced kidney injury. Int. Immunopharmacol. 2015, 28, 500–506.
27. Zhang, D. M., Li, Y. C., Xu, D., Ding, X. Q. et al., Protection of curcumin against fructose-induced hyperuricaemia and renal endothelial dysfunction involves NO-mediated JAK-STAT signalling in rats. Food Chem. 2012, 134, 2184–2193.
28. Ding, X. Q., Gu, T. T., Wang, W., Song, L. et al., Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206. Mol. Nutr. Food Res. 2015, 59, 2355–2370.
29. Prince, P. D., Lanzi, C. R., Toblli, J. E., Elesgaray, R. et al., Dietary (-)-epicatechin mitigates oxidative stress, NO metabolism alterations, and inflammation in renal cortex from fructose-fed rats. Free Radic. Biol. Med. 2016, 90, 35–46.
30. Yang, M., Liu, C., Jiang, J., Zuo, G. et al., Ginger extract diminishes chronic fructose consumption-induced kidney injury through suppression of renal overexpression of proinflammatory cytokines in rats. BMC Complement Altern. Med. 2014, 14, 174.
31. El-Bassossy, H. M., Shaltout, H. A., Allopurinol alleviates hypertension and proteinuria in high fructose, high salt and high fat induced model of metabolic syndrome. Transl. Res. 2015, 165, 621–630.
32. Wang, C. P., Wang, X., Zhang, X., Shi, Y. W. et al., Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice. J. Pharm. Pharm. Sci. 2010, 13, 411–427.
33. Cho, Y. M., Onodera, H., Ueda, M., Imai, T. et al., A 13-week subchronic toxicity study of dietary administered morin in F344 rats. Food Chem. Toxicol. 2006, 44, 891–897.
34. Wu, H. T., Ou, H. Y., Hung, H. C., Su, Y. C. et al., A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. Diabetologia 2016, 59, 1732–1742.
35. Barone, S., Fussell, S. L., Singh, A. K., Lucas, F. et al., Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J. Biol. Chem. 2009, 284, 5056–5066.
36. Sugimoto, K., Hosotani, T., Kawasaki, T., Nakagawa, K. et al., Eucalyptus leaf extract suppresses the postprandial elevation of portal, cardiac and peripheral fructose concentrations after sucrose ingestion in rats. J. Clin. Biochem. Nutr. 2010, 46, 205–211.
37. −/− mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2015, 309, G779–G790.
38. Glushakova, O., Kosugi, T., Roncal, C., Mu, W. et al., Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J. Am. Soc. Nephrol. 2008, 19, 1712–1720.
39. Cirillo, P., Gersch, M. S., Mu, W., Scherer, P. M. et al., Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J. Am. Soc. Nephrol. 2009, 20, 545–553.
40. Elks, C. M., Francis, J., Central adiposity, systemic inflammation, and the metabolic syndrome. Curr. Hypertens. Rep. 2010, 12, 99–104.
41. Kabul, S., Shepler, B., A review investigating the effect of allopurinol on the progression of kidney disease in hyperuricemic patients with chronic kidney disease. Clin. Ther. 2012, 34, 2293–2296.
42. Goicoechea, M., Garcia de Vinuesa, S., Verdalles, U., Verde, E. et al., Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am. J. Kidney Dis. 2015, 65, 543–549.
43. Le, M. T., Frye, R. F., Rivard, C. J., Cheng, J. et al., Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism 2012, 61, 641–651.
44. Kayano, T., Burant, C. F., Fukumoto, H., Gould, G. W. et al., Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6). J. Biol. Chem. 1990, 265, 13276–13282.
45. Wood, I. S., Trayhurn, P., Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br. J. Nutr. 2003, 89, 3–9.
46. Wang, M. X., Zhao, X. J., Chen, T. Y., Liu, Y. L. et al., Nuciferine alleviates renal injury by inhibiting inflammatory responses in fructose-fed rats. J. Agric. Food Chem. 2016, 64, 7899–7910.
47. Aoyama, M., Isshiki, K., Kume, S., Chin-Kanasaki, M. et al., Fructose induces tubulointerstitial injury in the kidney of mice. Biochem. Biophys. Res. Commun. 2012, 419, 244–249.
48. Leucht, K., Fischbeck, A., Caj, M., Liebisch, G. et al., Sphingomyelin and phosphatidylcholine contrarily affect the induction of apoptosis in intestinal epithelial cells. Mol. Nutr. Food Res. 2014, 58, 782–798.
49. Lan, T., Shen, X., Liu, P., Liu, W. et al., Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway. Arch. Biochem. Biophys. 2010, 502, 112–120.
50. Awad, A. S., Rouse, M. D., Khutsishvili, K., Huang, L. et al., Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int. 2011, 79, 1090–1098.
51. Siehler, S., Wang, Y., Fan, X., Windh, R. T. et al., Sphingosine 1-phosphate activates nuclear factor-kappa B through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells. J. Biol. Chem. 2001, 276, 48733–48739.
52. Luheshi, N. M., Giles, J. A., Lopez-Castejon, G., Brough, D., Sphingosine regulates the NLRP3-inflammasome and IL-1beta release from macrophages. Eur. J. Immunol. 2012, 42, 716–725.
53. Wang, C., Pan, Y., Zhang, Q. Y., Wang, F. M. et al., Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One 2012, 7, e38285.
54. Li, Y., Zhu, X., Xu, W., Wang, D. et al., miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42. Biochem. Biophys. Res. Commun. 2013, 431, 560–565.
55. Medrano, S., Monteagudo, M. C., Sequeira-Lopez, M. L., Pentz, E. S. et al., Two microRNAs, miR-330 and miR-125b-5p, mark the juxtaglomerular cell and balance its smooth muscle phenotype. Am. J. Physiol. Renal Physiol. 2012, 302, F29–F37.
56. Ortega, F. J., Cardona-Alvarado, M. I., Mercader, J. M., Moreno-Navarrete, J. M. et al., Circulating profiling reveals the effect of a polyunsaturated fatty acid-enriched diet on common microRNAs. J. Nutr. Biochem. 2015, 26, 1095–1101.
57. Ahmad, A., Li, Y., Sarkar, F. H., The bounty of nature for changing the cancer landscape. Mol. Nutr. Food Res. 2016, 60, 1251–1263.
58. Jeyapalan, Z., Deng, Z., Shatseva, T., Fang, L. et al., Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 2011, 39, 3026–3041.
59. Dhayat, S. A., Mardin, W. A., Seggewiss, J., Strose, A. J. et al., MicroRNA profiling implies new markers of gemcitabine chemoresistance in mutant p53 pancreatic ductal adenocarcinoma. PLoS One 2015, 10, e0143755.
60. Chung, S. S., Oliva, B., Dwabe, S., Vadgama, J. V., Combination treatment with flavonoid morin and telomerase inhibitor MST312 reduces cancer stem cell traits by targeting STAT3 and telomerase. Int. J. Oncol. 2016, 49, 487–498.
61. Zhao, J., XX, W. H. W., Kang, X. M., Shen, X. et al., Acute toxicity study of morin in mice. Nat. Prod. Res. Dev. 2015, 27, 699–705.